dactinomycin has been researched along with cardiovascular agents in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Garami, M; Gardner, DG | 1 |
| Inoue, M; Mizukami, H; Suzuki, H; Tanabe, H | 1 |
2 other study(ies) available for dactinomycin and cardiovascular agents
| Article | Year |
|---|---|
Doxorubicin selectively inhibits brain versus atrial natriuretic peptide gene expression in cultured neonatal rat myocytes.
Topics: Animals; Anticholesteremic Agents; Antineoplastic Agents; Atrial Natriuretic Factor; Cardiovascular Agents; Cell Survival; Cells, Cultured; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Gene Expression; Heart Atria; Natriuretic Peptide, Brain; Probucol; Promoter Regions, Genetic; Protein Synthesis Inhibitors; Rats; Razoxane; RNA, Messenger; Transfection | 1999 |
Selective regulation of multidrug resistance protein in vascular smooth muscle cells by the isoquinoline alkaloid coptisine.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Berberine; Berberine Alkaloids; Cardiovascular Agents; Cell Line; Cell Line, Tumor; Coptis; Dactinomycin; Drug Resistance, Multiple; Gene Expression Regulation; Genes, MDR; Humans; Membrane Transport Proteins; Mice; Molecular Structure; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Rhodamines; RNA, Messenger; Up-Regulation | 2010 |